相似文献
1
The ubiquitin proteasome system as a potential therapeutic target for systemic sclerosis.
Transl Res. 2018 Aug;198:17-28. doi: 10.1016/j.trsl.2018.03.003. Epub 2018 Mar 29.
2
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets.
Autoimmun Rev. 2007 Dec;7(2):121-6. doi: 10.1016/j.autrev.2007.02.020. Epub 2007 Mar 28.
3
Targeting the ubiquitin proteasome system in haematological malignancies.
Blood Rev. 2013 Nov;27(6):297-304. doi: 10.1016/j.blre.2013.10.002. Epub 2013 Oct 19.
4
Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.
Expert Rev Clin Immunol. 2016;12(2):115-35. doi: 10.1586/1744666X.2016.1115717. Epub 2015 Dec 2.
5
Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies.
Antioxid Redox Signal. 2014 Dec 10;21(17):2322-43. doi: 10.1089/ars.2013.5823. Epub 2014 Oct 1.
6
Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response.
Prog Neurobiol. 2012 May;97(2):101-26. doi: 10.1016/j.pneurobio.2011.10.001. Epub 2011 Oct 20.
7
Early inflammatory players in cutanous fibrosis.
J Dermatol Sci. 2017 Sep;87(3):228-235. doi: 10.1016/j.jdermsci.2017.06.009. Epub 2017 Jun 15.
8
The Ubiquitin-Proteasome System in Immune Cells.
Biomolecules. 2021 Jan 5;11(1):60. doi: 10.3390/biom11010060.
9
The ubiquitin proteasome system as a potential target for the treatment of neurodegenerative diseases.
Curr Pharm Des. 2013;19(18):3305-14. doi: 10.2174/1381612811319180013.
10
A Tale of Two Proteolytic Machines: Matrix Metalloproteinases and the Ubiquitin-Proteasome System in Pulmonary Fibrosis.
Int J Mol Sci. 2020 May 29;21(11):3878. doi: 10.3390/ijms21113878.
引用本文的文献
1
PDGF Promotes Dermal Fibroblast Activation a Novel Mechanism Mediated by Signaling Through MCHR1.
Front Immunol. 2021 Nov 29;12:745308. doi: 10.3389/fimmu.2021.745308. eCollection 2021.
2
Bortezomib Inhibits Lung Fibrosis and Fibroblast Activation without Proteasome Inhibition.
Am J Respir Cell Mol Biol. 2022 Jan;66(1):23-37. doi: 10.1165/rcmb.2021-0112OC.
3
The Ubiquitin Proteasome System and Skin Fibrosis.
Mol Diagn Ther. 2021 Jan;25(1):29-40. doi: 10.1007/s40291-020-00509-z. Epub 2021 Jan 12.
4
A Plot TWIST in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2020 Nov 1;202(9):1214-1216. doi: 10.1164/rccm.202006-2506ED.
5
Kelch-like protein 42 is a profibrotic ubiquitin E3 ligase involved in systemic sclerosis.
J Biol Chem. 2020 Mar 27;295(13):4171-4180. doi: 10.1074/jbc.AC119.012066. Epub 2020 Feb 17.
6
[Research progress on selective immunoproteasome inhibitors].
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019 Dec 25;48(6):688-694. doi: 10.3785/j.issn.1008-9292.2019.12.15.
7
Proteasome-associated cysteine deubiquitinases are molecular targets of environmental optical brightener compounds.
J Cell Biochem. 2019 Aug;120(8):14065-14075. doi: 10.1002/jcb.28682. Epub 2019 Apr 8.
本文引用的文献
1
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.
J Am Soc Nephrol. 2018 Feb;29(2):591-605. doi: 10.1681/ASN.2017070818. Epub 2017 Dec 14.
2
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
Kidney Int. 2018 Mar;93(3):670-680. doi: 10.1016/j.kint.2017.09.023. Epub 2017 Dec 8.
3
Immunoproteasome subunit ß5i/LMP7-deficiency in atherosclerosis.
Sci Rep. 2017 Oct 17;7(1):13342. doi: 10.1038/s41598-017-13592-w.
4
Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasome.
Br J Pharmacol. 2018 Jan;175(1):38-52. doi: 10.1111/bph.14069. Epub 2017 Nov 29.
5
Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice.
Oncotarget. 2017 Feb 7;8(31):50873-50888. doi: 10.18632/oncotarget.15141. eCollection 2017 Aug 1.
6
CANDLE Syndrome As a Paradigm of Proteasome-Related Autoinflammation.
Front Immunol. 2017 Aug 9;8:927. doi: 10.3389/fimmu.2017.00927. eCollection 2017.
7
The immunoproteasome: An old player with a novel and emerging role in alloimmunity.
Am J Transplant. 2017 Dec;17(12):3033-3039. doi: 10.1111/ajt.14435. Epub 2017 Aug 30.
8
Targeted Protein Degradation: from Chemical Biology to Drug Discovery.
Cell Chem Biol. 2017 Sep 21;24(9):1181-1190. doi: 10.1016/j.chembiol.2017.05.024. Epub 2017 Jun 22.
9
No prolongation of skin allograft survival by immunoproteasome inhibition in mice.
Mol Immunol. 2017 Aug;88:32-37. doi: 10.1016/j.molimm.2017.05.022. Epub 2017 Jun 2.
10
The Logic of the 26S Proteasome.
Cell. 2017 May 18;169(5):792-806. doi: 10.1016/j.cell.2017.04.023.
Zotero 插件